When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study

Anne-Pascale Meert; Anne-Claire Toffart; Muriel Picard; Paul Jaubert; Aude Gibelin; Philippe Bauer; Djamel Mokart; Andry Van De Louw; Stefan Hatzl; Gabriel Moreno-Gonzales; Gaelle Rousseau-Bussac; Fabrice Bruneel; Luca Montini; Anne-Sophie Moreau; Dorothée Carpentier; Amelie Seguin; Pleun Hemelaar; Elie Azoulay; Virginie Lemiale

doi:10.1016/j.bulcan.2022.04.014

When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study

Anne-Pascale Meert
, Anne-Claire Toffart
, Muriel Picard
, Paul Jaubert
, Aude Gibelin
, Philippe Bauer
, Djamel Mokart
, Andry Van De Louw
, Stefan Hatzl
, Gabriel Moreno-Gonzales
, Gaelle Rousseau-Bussac
, Fabrice Bruneel
, Luca Montini
, Anne-Sophie Moreau
, Dorothée Carpentier
, Amelie Seguin
, Pleun Hemelaar
, Elie Azoulay
, Virginie Lemiale

Université libre de Bruxelles
Université Grenoble Alpes
CHU de Toulouse
Université Paris Cité
Hôpital Tenon
Mayo Clinic Rochester, MN
Institut Paoli Calmettes
Pennsylvania State University
Medical University of Graz
Hospital Universitari de Bellvitge-IDIBELL
CHI de Créteil
Centre Hospitalier de Versailles
Université de Lille
CHU Hôpitaux de Rouen
CHU de Nantes
Radboud University Nijmegen
Assistance publique – Hôpitaux de Paris

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	916-924
Numero di pagine	9
Rivista	Bulletin du Cancer
Volume	109
DOI	https://doi.org/10.1016/j.bulcan.2022.04.014
Stato di pubblicazione	Pubblicato - 2022

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Adult
Adverse event
Aged
Hospital Mortality
Hospitalization
Humans
ICU
Intensive Care Units
Middle Aged
Neoplasms
Outcome
Retrospective Studies
Solid tumours
Survival Rate
Targeted therapy

Accesso al documento

10.1016/j.bulcan.2022.04.014

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Meert, A.-P., Toffart, A.-C., Picard, M., Jaubert, P., Gibelin, A., Bauer, P., Mokart, D., Van De Louw, A., Hatzl, S., Moreno-Gonzales, G., Rousseau-Bussac, G., Bruneel, F., Montini, L., Moreau, A.-S., Carpentier, D., Seguin, A., Hemelaar, P., Azoulay, E., & Lemiale, V. (2022). When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study. Bulletin du Cancer, 109, 916-924. https://doi.org/10.1016/j.bulcan.2022.04.014

@article{9304a48895ab4548a483630207ca180b,

title = "When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study",

abstract = "N/A",

keywords = "Adult, Adverse event, Aged, Hospital Mortality, Hospitalization, Humans, ICU, Intensive Care Units, Middle Aged, Neoplasms, Outcome, Retrospective Studies, Solid tumours, Survival Rate, Targeted therapy, Adult, Adverse event, Aged, Hospital Mortality, Hospitalization, Humans, ICU, Intensive Care Units, Middle Aged, Neoplasms, Outcome, Retrospective Studies, Solid tumours, Survival Rate, Targeted therapy",

author = "Anne-Pascale Meert and Anne-Claire Toffart and Muriel Picard and Paul Jaubert and Aude Gibelin and Philippe Bauer and Djamel Mokart and \{Van De Louw\}, Andry and Stefan Hatzl and Gabriel Moreno-Gonzales and Gaelle Rousseau-Bussac and Fabrice Bruneel and Luca Montini and Anne-Sophie Moreau and Doroth{\'e}e Carpentier and Amelie Seguin and Pleun Hemelaar and Elie Azoulay and Virginie Lemiale",

year = "2022",

doi = "10.1016/j.bulcan.2022.04.014",

language = "English",

volume = "109",

pages = "916--924",

journal = "Bulletin du Cancer",

issn = "0007-4551",

publisher = "John Libbey",

}

Meert, A-P, Toffart, A-C, Picard, M, Jaubert, P, Gibelin, A, Bauer, P, Mokart, D, Van De Louw, A, Hatzl, S, Moreno-Gonzales, G, Rousseau-Bussac, G, Bruneel, F, Montini, L, Moreau, A-S, Carpentier, D, Seguin, A, Hemelaar, P, Azoulay, E & Lemiale, V 2022, 'When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study', Bulletin du Cancer, vol. 109, pagg. 916-924. https://doi.org/10.1016/j.bulcan.2022.04.014

TY - JOUR

T1 - When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study

AU - Meert, Anne-Pascale

AU - Toffart, Anne-Claire

AU - Picard, Muriel

AU - Jaubert, Paul

AU - Gibelin, Aude

AU - Bauer, Philippe

AU - Mokart, Djamel

AU - Van De Louw, Andry

AU - Hatzl, Stefan

AU - Moreno-Gonzales, Gabriel

AU - Rousseau-Bussac, Gaelle

AU - Bruneel, Fabrice

AU - Montini, Luca

AU - Moreau, Anne-Sophie

AU - Carpentier, Dorothée

AU - Seguin, Amelie

AU - Hemelaar, Pleun

AU - Azoulay, Elie

AU - Lemiale, Virginie

PY - 2022

Y1 - 2022

N2 - N/A

AB - N/A

KW - Adult

KW - Adverse event

KW - Aged

KW - Hospital Mortality

KW - Hospitalization

KW - Humans

KW - ICU

KW - Intensive Care Units

KW - Middle Aged

KW - Neoplasms

KW - Outcome

KW - Retrospective Studies

KW - Solid tumours

KW - Survival Rate

KW - Targeted therapy

KW - Adult

KW - Adverse event

KW - Aged

KW - Hospital Mortality

KW - Hospitalization

KW - Humans

KW - ICU

KW - Intensive Care Units

KW - Middle Aged

KW - Neoplasms

KW - Outcome

KW - Retrospective Studies

KW - Solid tumours

KW - Survival Rate

KW - Targeted therapy

UR - http://hdl.handle.net/10807/214807

U2 - 10.1016/j.bulcan.2022.04.014

DO - 10.1016/j.bulcan.2022.04.014

M3 - Article

SN - 0007-4551

VL - 109

SP - 916

EP - 924

JO - Bulletin du Cancer

JF - Bulletin du Cancer

ER -

When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo